3 results  1 of 1 

1 Characteristics of Immune-Related Thyroid Adverse Events in Patients Treated with PD-1/PD-L1 Inhibitors
Jee Hee Yoon, A Ram Hong, Hee Kyung Kim, Ho-Cheol Kang
Endocrinol Metab.2021;36(2):413-423.   Published online 2021 April 6     DOI: http://dx.doi.org/10.3803/EnM.2020.906
      
2 Immune Checkpoint Inhibitors for Non-Small-Cell Lung Cancer with Brain Metastasis : The Role of Gamma Knife Radiosurgery
Min Ho Lee, Kyung-Rae Cho, Jung Won Choi, Doo-Sik Kong, Ho Jun Seol, Do-Hyun Nam, Hyun Ae Jung, Jong-Mu Sun, Se-Hoon Lee, Jin Seok Ahn, Myung-Ju Ahn, Keunchil Park, Jung-Il Lee
J Korean Neurosurg Soc.2021;64(2):271-281.   Published online 2020 December 4     DOI: http://dx.doi.org/10.3340/jkns.2020.0135
      
3 Programmed death-1 pathway blockade produces a synergistic antitumor effect: combined application in ovarian cancer
Xinxin Zhu, Jinghe Lang
J Gynecol Oncol.2017;28(5):e64.  Published online 2017 June 5     DOI: http://dx.doi.org/10.3802/jgo.2017.28.e64
      

 1 of 1